Study investigating advanced MRI scans to detect prostate cancer set to begin
the ONA take:
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial. Tim Dudderidge, a consultant urological surgeon based at Southampton General Hospital, one of the ten centers involved in the trial, has cited the shortcomings of the traditional biopsy procedure; men with a raised PSA are typically advised to have a biopsy, but the biopsy may either miss existing cancer or lead to unnecessary surgery in the case of slow-growing cancer.
Traditional technique uses an ultrasound probe to guide a needle through the rectal walls and into the prostate for sample extraction. The procedure is normally performed on a patient under local anesthetic. The new procedure under review uses cutting-edge image technology, multi parametric (MP) MRI, to create very accurate scans to help determine location, size, and aggressiveness of the prostate cancer.
If successful, the advanced MRI technique could eliminate or reduce the need for invasive biopsies in some men, and provide greater detail at an earlier stage for men with conditions that warrant treatment. The trial involves ten centers spread across the country, with the goal to recruit 700 individuals with prostate cancer by October 2015 for participation.
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|